A Phase 1B/2 Study Of Gb5121, A Novel, Highly Selective, Potent, And Cns-Penetrant Btk Inhibitor For Relapsed/Refractory Primary/Secondary Cns Lymphoma And Primary Vitreoretinal Lymphoma
Gb5121
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 1B/2 Study Of Gb5121, A Novel, Highly Selective, Potent, And Cns-Penetrant Btk Inhibitor For Relapsed/Refractory Primary/Secondary Cns Lymphoma And Primary Vitreoretinal Lymphoma ### Output: Gb5121